ArticleFrontiers in ophthalmology2025
Predicting progressive vision loss in glaucoma patients using functional principal component analysis and electronic health records.
Article in Frontiers in ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Glaucoma is a leading cause of irreversible blindness worldwide. Predicting a patient's future clinical trajectory would help physicians personalize management. We present a novel approach for predicting patient visual field (VF) progression by combining Functional Principal Component Analysis (FPCA) with electronic health record (EHR) data. Methods: We identified glaucoma patients using diagnosis codes who had >=3 VF tests. We developed a 2-stage modeling pipeline: 1) Patients were split 80:10:10 into train, validation, and test sets and classified as fast-progressors or slow-progressors. 2) FPCA was used to predict mean deviation (MD) trajectories over 10 years after the baseline year of VF exams, using the first 2 principal components. To make predictions, the model uses up to one year of baseline VF and EHR data as input, but can flexibly make predictions from as few as a single VF test. Results: 15,764 VF tests belonging to 2,372 patients were included, of which 8.92% of eyes were fast progressors. On the held-out test set, predictions over 10 years of future MD trajectories using baseline VF and EHR clinical data yielded an R Conclusion: A novel modeling approach combining FPCA with clinical data from EHR was able to model longitudinal clinical trajectories of glaucoma patients. This method is well-suited for modeling longitudinal healthcare data, handling sparse and irregular observation schedules with a varying number of inputs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.